|
Patent 5686246: Detecting genetic predisposition to periodontal disease
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)
Patent 5686247: Detection of mammary tumor virus env gene-like sequences in human breast cancer
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)
Patent 5686248: Fungal stress proteins
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)
Patent 5686249: Test for determining frost hardiness of conifer seedlings and protein and antibody related thereto
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay :)
Patent 5686250: Antibodies to LGE.sub.2 -protein antigens
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay :)
Patent 5686251: Naphthyridinium derivatives
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay :)
Patent 5686252: Immunoassay method utilizing zeta potential and immunoassay kit
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay :)
Patent 5686253: Method of stabilizing enzyme conjugates
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay : Assay in which an enzyme present is a label : Bacteria or actinomycetales)
Patent 5686254: Reduction in first slide bias and improved enzyme stability by the incorporation of diaryl tellurides in thin-film immunoassay elements
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay : Assay in which an enzyme present is a label : Bacteria or actinomycetales)
Patent 5686255: Compositions and methods for diagnosing schizophrenia
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay : Involving a micro-organism or cell membrane bound antigen or cell membrane bound receptor or cell membrane bound antibody or microbial lysate : Animal cell :)
Patent 5686256: Carbohydrate-based vaccine and diagnostic reagent for trichinosis
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay : Involving a micro-organism or cell membrane bound antigen or cell membrane bound receptor or cell membrane bound antibody or microbial lysate : Animal cell : Parasite or protozoa :)
Patent 5686257: Binding compositions for mammalian T cell antigens and related reagents
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay : Involving a micro-organism or cell membrane bound antigen or cell membrane bound receptor or cell membrane bound antibody or microbial lysate : Animal cell : Leukocyte (e.g., lymphocyte, granulocyte, monocyte, etc.) :)
Patent 5686258: Chemiluminescent detection of hydrolytic enzymes using an acridan
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay : Assay in which an enzyme present is a label : Enzyme produces product which is part of another reaction system (e.g., cyclic reaction, cascade reaction, etc.) : Escherichia coli)
Patent 5686259: Assay method for the detection of 26kd TNF prohormone
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay : Assay in which an enzyme present is a label : Heterogeneous or solid phase assay system (e.g., ELISA, etc.) : Escherichia coli)
Patent 5686260: Method and composition for the enzymic determination of aspartame
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving hydrolase : Involving proteinase : Involving phosphatase)
Patent 5686261: Xanthylium dyes that are well retained in mitochondria
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving fixed or stabilized, nonliving microorganism, cell, or tissue (e.g., processes of staining, stabilizing, dehydrating, etc.; compositions used therefore, etc.) : Determining presence or kind of micro-organism; use of selective media)
Patent 5686262: Recycle process for the production of low-cost soluble collagen
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Enzymatic production of a protein or polypeptide (e.g., enzymatic hydrolysis, etc.) : Dehydrogenating; dehydroxylating)
Patent 5686263: Method for enhancing gene expression
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Recombinant DNA technique included in method of making a protein or polypeptide : Dehydrogenating; dehydroxylating)
Patent 5686264: Compositions and methods relating to transdominant Tat mutants
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Recombinant DNA technique included in method of making a protein or polypeptide : Dehydrogenating; dehydroxylating)
Patent 5686265: Leukocyte adhesion receptors
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Recombinant DNA technique included in method of making a protein or polypeptide : Dehydrogenating; dehydroxylating)
Patent 5686266: Human brain sodium dependent inorganic phosphate cotransproter and related nucleic acid compounds
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Recombinant DNA technique included in method of making a protein or polypeptide : Dehydrogenating; dehydroxylating)
Patent 5686267: Nucleic acid molecule encoding antigen associated with lyme disease
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Recombinant DNA technique included in method of making a protein or polypeptide : Antigens : Forming an aryl ring from "A" ring)
Patent 5686268: Fused proteins
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Recombinant DNA technique included in method of making a protein or polypeptide : Hormones and fragments thereof : Forming an aryl ring from "A" ring)
Patent 5686269: Method of diagnosing Alzheimer's disease by detecting the level of cathepsin D in cerebrospinal fluid
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay :)
Patent 5686270: Production of antigens by self-assembly of polypeptide components
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : PROCESS OF MUTATION, CELL FUSION, OR GENETIC MODIFICATION : Introduction of a polynucleotide molecule into or rearrangement of nucleic acid within an animal cell : The polynucleotide is encapsidated within a virus or viral coat : Acyclic)
Patent 5686271: Apparatus for performing magnetic cycle reaction
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing compound containing saccharide radical : Preparing nitrogen-containing saccharide : N-glycoside : Nucleotide : Polynucleotide (e.g., nucleic acid, oligonucleotide, etc.) : Containing three or more saccharide radicals (e.g., liquidomycin, neomycin, lividomycin, etc.))
Patent 5686272: Amplification of RNA sequences using the ligase chain reaction
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing compound containing saccharide radical : Preparing nitrogen-containing saccharide : N-glycoside : Nucleotide : Polynucleotide (e.g., nucleic acid, oligonucleotide, etc.) : Acellular exponential or geometric amplification (e.g., PCR, etc.) :)
Patent 5686273: Fermentation process for producing natamycin with additional carbon and nitrogen
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing heterocyclic carbon compound having only O, N, S, Se, or Te as ring hetero atoms : Containing two or more hetero rings : Containing at least two hetero rings bridged or fused among themselves or bridged or fused with a common carbocyclic ring system, (e.g., rifamycin, etc.) : Nucleotide)
Patent 5686274: Method for precipitating natural advermectins
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing heterocyclic carbon compound having only O, N, S, Se, or Te as ring hetero atoms : Oxygen as only ring hetero atom : Containing six-membered hetero ring (e.g., fluorescein, etc.) : Nucleotide)
Patent 5686275: Synthesis of homochiral 2-hydroxy acids
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing oxygen-containing organic compound : Containing a carboxyl group : Hydroxy carboxylic acid : Dicarboxylic acid having four or less carbon atoms (e.g., fumaric, maleic, etc.))
Patent 5686276: Bioconversion of a fermentable carbon source to 1,3-propanediol by a single microorganism
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing oxygen-containing organic compound : Containing hydroxy group : Acyclic : Polyhydric : Substrate contains inorganic compound, other than water)
Patent 5686277: Fermentation process for preparing xylitol using mutant cells
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing oxygen-containing organic compound : Containing hydroxy group : Acyclic : Polyhydric : Substrate contains inorganic compound, other than water)
Patent 5686278: Methods for enhanced retrovirus-mediated gene transfer
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : PROCESS OF MUTATION, CELL FUSION, OR GENETIC MODIFICATION : Introduction of a polynucleotide molecule into or rearrangement of nucleic acid within an animal cell : The polynucleotide is encapsidated within a virus or viral coat : Acyclic)
Patent 5686279: Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : PROCESS OF MUTATION, CELL FUSION, OR GENETIC MODIFICATION : Introduction of a polynucleotide molecule into or rearrangement of nucleic acid within an animal cell : The polynucleotide is encapsidated within a virus or viral coat : Helper virus is present : Ethanol)
Patent 5686280: Efficient gene transfer into primary lymphocytes obviating the need for drug selection
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : PROCESS OF MUTATION, CELL FUSION, OR GENETIC MODIFICATION : Introduction of a polynucleotide molecule into or rearrangement of nucleic acid within an animal cell : The polynucleotide is encapsidated within a virus or viral coat : Acyclic)
Patent 5686281: Chimeric receptor molecules for delivery of co-stimulatory signals
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : PROCESS OF MUTATION, CELL FUSION, OR GENETIC MODIFICATION : Introduction of a polynucleotide molecule into or rearrangement of nucleic acid within an animal cell : The polynucleotide is encapsidated within a virus or viral coat : Acyclic)
Patent 5686282: DNA encoding the pseudomonas fluorescens sensor/kinase element, lemA, and its use in activating gene expression
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : PROCESS OF MUTATION, CELL FUSION, OR GENETIC MODIFICATION : Introduction of a polynucleotide molecule into or rearrangement of nucleic acid within a microorganism (e.g., bacteria, protozoa, bacteriophage, etc.) : The polynucleotide is a plasmid or episome : Plasmid or episome contains DNA targeting homologous recombination to bacteriophage, viral, or chromosomal DNA within a microorganism : Ethanol)
Patent 5686283: Genomic DNA encoding the pseudomonas fluorescens alternative sigma factor, RpoS, capable of activating gene expression
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : PROCESS OF MUTATION, CELL FUSION, OR GENETIC MODIFICATION : Introduction of a polynucleotide molecule into or rearrangement of nucleic acid within a microorganism (e.g., bacteria, protozoa, bacteriophage, etc.) : The polynucleotide is a plasmid or episome : Plasmid or episome contains DNA targeting homologous recombination to bacteriophage, viral, or chromosomal DNA within a microorganism : Ethanol)
Patent 5686284: Alcohol acetyltransferase genes and use thereof
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ENZYME (E.G., LIGASES (6. ), ETC.), PROENZYME; COMPOSITIONS THEREOF; PROCESS FOR PREPARING, ACTIVATING, INHIBITING, SEPARATING, OR PURIFYING ENZYMES : Transferase other than ribonuclease (2.) : Acting on hydrogen peroxide as acceptor (1.11))
Patent 5686285: Norbornane type ester hydrolase
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ENZYME (E.G., LIGASES (6. ), ETC.), PROENZYME; COMPOSITIONS THEREOF; PROCESS FOR PREPARING, ACTIVATING, INHIBITING, SEPARATING, OR PURIFYING ENZYMES : Hydrolase (3. ) : Acting on ester bond (3.1) : Carboxylic ester hydrolase (3.1.1) : Ethanol)
Patent 5686286: hPDE IV-C: a novel human phosphodiesterase IV isozyme
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ENZYME (E.G., LIGASES (6. ), ETC.), PROENZYME; COMPOSITIONS THEREOF; PROCESS FOR PREPARING, ACTIVATING, INHIBITING, SEPARATING, OR PURIFYING ENZYMES : Hydrolase (3. ) : Acting on ester bond (3.1) : Ribonuclease (3.1.4) : Triglyceride splitting (e.g., lipase, etc. (3.1.1.3)))
Patent 5686287: Marek's disease virus vaccine
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : VIRUS OR BACTERIOPHAGE, EXCEPT FOR VIRAL VECTOR OR BACTERIOPHAGE VECTOR; COMPOSITION THEREOF; PREPARATION OR PURIFICATION THEREOF; PRODUCTION OF VIRAL SUBUNITS; MEDIA FOR PROPAGATING : Isomerase (5. ))
Patent 5686288: Huntingtin DNA, protein and uses thereof
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE : Recovery or purification)
Patent 5686289: Method and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE : Recovery or purification)
Patent 5686291: Corynebacterium SP. N having decomposability for ethanolamines
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, PER SE (E.G., PROTOZOA, ETC.); COMPOSITIONS THEREOF; PROCES OF PROPAGATING, MAINTAINING OR PRESERVING MICRO-ORGANISMS OR COMPOSITIONS THEREOF; PROCESS OF PREPARING OR ISOLATING A COMPOSITION CONTAINING A MICRO-ORGANISM; CULTURE MEDIA THEREFOR : Bacteria or actinomycetales; media therefor : Aliphatic)
Patent 5686292: Hepatocyte growth factor receptor antagonist antibodies and uses thereof
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : IMMUNOGLOBULIN, ANTISERUM, ANTIBODY, OR ANTIBODY FRAGMENT, EXCEPT CONJUGATE OR COMPLEX OF THE SAME WITH NONIMMUNOGLOBULIN MATERIAL : Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) : Binds receptor : Maleic anhydride monomer)
Patent 5686293: Sulfide-oxidizing bacteria
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, PER SE (E.G., PROTOZOA, ETC.); COMPOSITIONS THEREOF; PROCES OF PROPAGATING, MAINTAINING OR PRESERVING MICRO-ORGANISMS OR COMPOSITIONS THEREOF; PROCESS OF PREPARING OR ISOLATING A COMPOSITION CONTAINING A MICRO-ORGANISM; CULTURE MEDIA THEREFOR : Bacteria or actinomycetales; media therefor : Aliphatic)
Patent 5686294: Protein having heat-resistant malate dehydrogenase activity
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, PER SE (E.G., PROTOZOA, ETC.); COMPOSITIONS THEREOF; PROCES OF PROPAGATING, MAINTAINING OR PRESERVING MICRO-ORGANISMS OR COMPOSITIONS THEREOF; PROCESS OF PREPARING OR ISOLATING A COMPOSITION CONTAINING A MICRO-ORGANISM; CULTURE MEDIA THEREFOR : Bacteria or actinomycetales; media therefor : Transformants (e.g., recombinant DNA or vector or foreign or exogenous gene containing, fused bacteria, etc.) : Having five or less carbon atoms)
Patent 5686295: Process for the genetic manipulation of myxobacteria
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, PER SE (E.G., PROTOZOA, ETC.); COMPOSITIONS THEREOF; PROCES OF PROPAGATING, MAINTAINING OR PRESERVING MICRO-ORGANISMS OR COMPOSITIONS THEREOF; PROCESS OF PREPARING OR ISOLATING A COMPOSITION CONTAINING A MICRO-ORGANISM; CULTURE MEDIA THEREFOR : Bacteria or actinomycetales; media therefor : Transformants (e.g., recombinant DNA or vector or foreign or exogenous gene containing, fused bacteria, etc.) : Having five or less carbon atoms)
Patent 5686296: Yeast debris products
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, PER SE (E.G., PROTOZOA, ETC.); COMPOSITIONS THEREOF; PROCES OF PROPAGATING, MAINTAINING OR PRESERVING MICRO-ORGANISMS OR COMPOSITIONS THEREOF; PROCESS OF PREPARING OR ISOLATING A COMPOSITION CONTAINING A MICRO-ORGANISM; CULTURE MEDIA THEREFOR : Fungi : Yeast : Rhizopus)
Patent 5686297: Method of cleaning contaminated industrial equipment
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : PROCESS OF UTILIZING AN ENZYME OR MICRO-ORGANISM TO DESTROY HAZARDOUS OR TOXIC WASTE, LIBERATE, SEPARATE, OR PURIFY A PREEXISTING COMPOUND OR COMPOSITION THEREFORE; CLEANING OBJECTS OR TEXTILES : Treating gas, emulsion, or foam : Eimeria)
Patent 5686298: Enzymatic reduction method for the preparation of compounds useful for preparing taxanes
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : PROCESS OF UTILIZING AN ENZYME OR MICRO-ORGANISM TO DESTROY HAZARDOUS OR TOXIC WASTE, LIBERATE, SEPARATE, OR PURIFY A PREEXISTING COMPOUND OR COMPOSITION THEREFORE; CLEANING OBJECTS OR TEXTILES : Resolution of optical isomers or purification of organic compounds or composition containing same : Carbohydrate material recovered or purified)
Patent 5686299: Method and apparatus for determining nutrient stimulation of biological processes
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : APPARATUS : Including measuring or testing : Including mixing or agitation control)
Patent 5686300: Fluorescence detector
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : APPARATUS : Including measuring or testing : Means for measuring gas pressure or gas volume of gas evolved from or consumed in an enzymatic or microbial reaction : Including liquid dispenser means)
Patent 5686301: Culture vessel for cell cultures
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : APPARATUS : Bioreactor : Including semipermeable membrane or filter : Including a semi-permeable membrane or filter)
Patent 5686302: Device for removing sperm cells form seminal fluid
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : APPARATUS : Bioreactor : Dish, plate, or tray : Multicompartmented : Including hollow fiber or capillary)
Patent 5686303: Method of growing vertebrate skin in vitro
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE : Recovery or purification)
Patent 5686304: Cell culture apparatus and method
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE : Recovery or purification)
Patent 5686305: Establishment of new cell lines from Pseudaletia unipuncta with differential responses to baculovirus
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE : Insect cell, per se : Immunoglobulin or antibody binds a drug, hapten, hapten-carrier complex, or specifically identified chemical structure (e.g., theophylline, digoxin, etc.))
Patent 5686306: Methods and reagents for lengthening telomeres
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE : Fused or hybrid cell, per se : Immunoglobulin or antibody binds a drug, hapten, hapten-carrier complex, or specifically identified chemical structure (e.g., theophylline, digoxin, etc.))
Patent 5686307: Serum free medium for use in the formation of a histologically complete living human skin substitute
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE : Culture medium, per se : Contains a growth factor or growth regulator : Hollow)
Patent 5686308: Reagent and method for differential determination of leukocytes in blood
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : BIOLOGICAL CELLULAR MATERIAL TESTED : Acidity, basicity or neutralization number)
Patent 5686309: Method and apparatus for determination of hemoglobin content of individual red blood cells
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : HEMOGLOBIN, MYOGLOBIN, OR OCCULT BLOOD : Acidity, basicity or neutralization number)
Patent 5686310: Method for determination of the amount of either phosphotyrosine or phosphoserine in a protein
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : PEPTIDE, PROTEIN OR AMINO ACID : Mn, Te, Re, Fe, Ru, Os, Co, Rh, Ir, Ni, Pd, Pt)
Patent 5686311: Diagnosis of autism and treatment therefor
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : PEPTIDE, PROTEIN OR AMINO ACID : Mn, Te, Re, Fe, Ru, Os, Co, Rh, Ir, Ni, Pd, Pt)
Patent 5686312: Method of determining emissions from powder coatings
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : INCLUDING CHROMATOGRAPHY : Combustion with oxygen containing gas)
Patent 5686313: Method for preparation of microscopic, especially electron-microscopic, slides for the preparation of sections
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : INCLUDING SAMPLE PREPARATION : Stabilizing or preserving : Plural superposed layers)
Patent 5686314: Surface processing method effected for total-reflection X-ray fluorescence analysis
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : INCLUDING SAMPLE PREPARATION : Liberation or purification of sample or separation of material from a sample (e.g., filtering, centrifuging, etc.) : Plural superposed layers)
Patent 5686315: Assay device for one step detection of analyte
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : IMMUNOCHEMICAL PREGNANCY DETERMINATION : Rheumatoid factors)
Patent 5686316: Methods and reagents for the rapid determination of glycated hemoglobin
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : INVOLVING AN INSOLUBLE CARRIER FOR IMMOBILIZING IMMUNOCHEMICALS : Through a gel (e.g., Ouchterlony technique, etc.))
Patent 5686317: Method for forming an interconnect having a penetration limited contact structure for establishing a temporary electrical connection with a
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : WITH MEASURING OR TESTING : Electrical characteristic sensed : Altering electrical property by material removal)
Patent 5686318: Method of forming a die-to-insert permanent connection
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : WITH MEASURING OR TESTING : Packaging (e.g., with mounting, encapsulating, etc.) or treatment of packaged semiconductor : Altering electrical property by material removal)
Patent 5686319: Method for producing a diode
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : BONDING OF PLURAL SEMICONDUCTOR SUBSTRATES : Thinning of semiconductor substrate : And electrical conductor formation (i.e., metallization))
Patent 5686320: Method for forming semiconductor layer of thin film transistor by using temperature difference
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : On insulating substrate or layer (e.g., TFT, etc.) : Having insulated gate : Inverted transistor structure : Utilizing backside irradiation : Having blooming suppression structure (e.g., antiblooming drain, etc.))
Patent 5686321: Local punchthrough stop for ultra large scale integration devices
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Doping of semiconductive channel region beneath gate insulator (e.g., adjusting threshold voltage, etc.) : Introducing a dopant into the channel region of selected transistors)
Patent 5686322: Process for doping two levels of a double poly bipolar transistor after formation of second poly layer
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMING BIPOLAR TRANSISTOR BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Complementary bipolar transistors : Self-aligned)
Patent 5686323: Method of manufacturing a semiconductor device having an out diffusion preventing film
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMING BIPOLAR TRANSISTOR BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Self-aligned : Dopant implantation or diffusion : Simultaneously outdiffusing plural dopants from polysilicon or amorphous semiconductor)
Patent 5686324: Process for forming LDD CMOS using large-tilt-angle ion implantation
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Complementary insulated gate field effect transistors (i.e., CMOS) : Self-aligned : Utilizing gate sidewall structure : Plural doping steps : Plural wells)
Patent 5686325: Method for forming MESFET having T-shaped gate electrode
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMING SCHOTTKY JUNCTION (I.E., SEMICONDUCTOR-CONDUCTOR RECTIFYING JUNCTION CONTACT) : Combined with formation of ohmic contact to semiconductor region : From vapor phase)
Patent 5686326: Method of making thin film transistor
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : On insulating substrate or layer (e.g., TFT, etc.) : Having insulated gate : And additional electrical device on insulating substrate or layer : Complementary field effect transistors)
Patent 5686327: Method for fabricating semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Vertical channel : Having additional, nonmemory control electrode or channel portion (e.g., for accessing field effect transistor structure, etc.))
Patent 5686328: Semiconductor device and process for fabricating the same
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING DEVICE OR CIRCUIT EMISSIVE OF NONELECTRICAL SIGNAL : Including integrally formed optical element (e.g., reflective layer, luminescent material, contoured surface, etc.) : Liquid crystal component : Packaging (e.g., with mounting, encapsulating, etc.) or treatment of packaged semiconductor)
Patent 5686329: Method for forming a metal oxide semiconductor field effect transistor (MOSFET) having improved hot carrier immunity
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Including passive device (e.g., resistor, capacitor, etc.) : Capacitor : Stacked capacitor : Including doping of semiconductive region)
Patent 5686330: Method of making a self-aligned static induction transistor
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having junction gate (e.g., JFET, SIT, etc.) : Vertical channel : Multiple parallel current paths (e.g., grid gate, etc.) : Utilizing gate sidewall structure)
Patent 5686331: Fabrication method for semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Self-aligned : Source or drain doping : Utilizing gate sidewall structure : Contacts formed by selective growth or deposition)
Patent 5686332: Process for fabricating flash memory devices
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Having additional gate electrode surrounded by dielectric (i.e., floating gate) : Multiple interelectrode dielectrics or nonsilicon compound gate insulator : Stacked capacitor)
Patent 5686333: Nonvolatile semiconductor memory device and method of producing the same
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Having additional gate electrode surrounded by dielectric (i.e., floating gate) : Capacitor)
Patent 5686334: Method of making SRAM cell with thin film transistor using two polysilicon layers
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : On insulating substrate or layer (e.g., TFT, etc.) : Having insulated gate : Combined with electrical device not on insulating substrate or layer : Specified shape junction barrier (e.g., V-grooved junction, etc.))
Patent 5686335: Method of making high-performance and reliable thin film transistor (TFT) using plasma hydrogenation with a metal shield on the TFT channel
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : On insulating substrate or layer (e.g., TFT, etc.) : Having insulated gate : Complementary field effect transistors : Complementary field effect transistors)
Patent 5686336: Method of manufacture of four transistor SRAM cell layout
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Including passive device (e.g., resistor, capacitor, etc.) : Lateral bipolar transistor)
Patent 5686337: Method for fabricating stacked capacitors in a DRAM cell
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Including passive device (e.g., resistor, capacitor, etc.) : Capacitor : Having high dielectric constant insulator (e.g., Ta2O5, etc.) : Plural doping steps)
Patent 5686338: Process for fabricating high-resistance load resistors using dummy polysilicon in four-transistor SRAM devices
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING PASSIVE DEVICE (E.G., RESISTOR, CAPACITOR, ETC.) : Resistor : Deposited thin film resistor : Simultaneous introduction of plural dopants)
Patent 5686339: High dielectric constant capacitor and a fabricating method thereof
(ACTIVE SOLID-STATE DEVICES (E.G., TRANSISTORS, SOLID-STATE DIODES) : FIELD EFFECT DEVICE : Having insulated electrode (e.g., MOSFET, MOS diode) : Insulated gate capacitor or insulated gate transistor combined with capacitor (e.g., dynamic memory cell) : Stacked capacitor : With means to insulate adjacent storage nodes (e.g., channel stops or field oxide))
Patent 5686340: Manufacturing method of CMOS transistor
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Complementary insulated gate field effect transistors (i.e., CMOS) : Self-aligned : Plural doping steps : Plural doping steps)
Patent 5686341: Method of fabricating an electrically alterable resistive component using germanium
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : DIRECT APPLICATION OF ELECTRICAL CURRENT : To alter conductivity of fuse or antifuse element : And electrical conductor formation (i.e., metallization))
Patent 5686342: Method for insulating semiconductor elements
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Total dielectric isolation : With electrolytic treatment step : Porous semiconductor formation : Plural doping steps)
Patent 5686343: Process for isolating a semiconductor layer on an insulator
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Total dielectric isolation : With epitaxial semiconductor formation : Semiconductor islands formed upon insulating substrate or layer (e.g., mesa isolation, etc.))
Patent 5686344: Device isolation method for semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Grooved and refilled with deposited dielectric material : Combined with formation of recessed oxide by localized oxidation : Dopant addition)
Patent 5686345: Trench mask for forming deep trenches in a semiconductor substrate, and method of using same
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Combined with coating step : Formation of groove or trench : Plural coating steps : Utilizing particulate abradant)
Patent 5686346: Method for enhancing field oxide thickness at field oxide perimeters
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Recessed oxide by localized oxidation (i.e., LOCOS) : Reflow of insulator)
Patent 5686347: Self isolation manufacturing method
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Including isolation structure : Recessed oxide formed by localized oxidation (i.e., LOCOS) : Doping region beneath recessed oxide (e.g., to form chanstop, etc.) : Contacts formed by selective growth or deposition)
Patent 5686348: Process for forming field isolation structure with minimized encroachment effect
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Recessed oxide by localized oxidation (i.e., LOCOS) : Dopant addition : Masking of groove sidewall)
Patent 5686349: Fabrication of a thin film transistor and production of a liquid crystal display apparatus
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF SEMICONDUCTIVE ACTIVE REGION ON ANY SUBSTRATE (E.G., FLUID GROWTH, DEPOSITION) : Amorphous semiconductor : Deposition utilizing plasma (e.g., glow discharge, etc.) : Hydrogen plasma (i.e., hydrogenization))
Patent 5686350: Method for fabricating defect-free compound semiconductor thin film on dielectric thin film
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF SEMICONDUCTIVE ACTIVE REGION ON ANY SUBSTRATE (E.G., FLUID GROWTH, DEPOSITION) : On insulating substrate or layer : Ionized radiation (e.g., corpuscular or plasma treatment, etc.))
Patent 5686351: Semimetal-semiconductor heterostructures and multilayers
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING DEVICE OR CIRCUIT EMISSIVE OF NONELECTRICAL SIGNAL : Compound semiconductor : Heterojunction : Packaging (e.g., with mounting, encapsulating, etc.) or treatment of packaged semiconductor)
Patent 5686352: Method for making a tab semiconductor device with self-aligning cavity and intrinsic standoff
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : PACKAGING (E.G., WITH MOUNTING, ENCAPSULATING, ETC.) OR TREATMENT OF PACKAGED SEMICONDUCTOR : Metallic housing or support : Lead frame : Utilizing a coating to perfect the dicing)
Patent 5686353: Semiconductor device and manufacturing method thereof
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : WITH MEASURING OR TESTING : Packaging (e.g., with mounting, encapsulating, etc.) or treatment of packaged semiconductor : Altering electrical property by material removal)
Patent 5686354: Dual damascene with a protective mask for via etching
(ETCHING A SUBSTRATE: PROCESSES : FORMING OR TREATING ELECTRICAL CONDUCTOR ARTICLE (E.G., CIRCUIT, ETC.) : Forming or treating of groove or through hole : Filling or coating of groove or through hole with a conductor to form an electrical interconnection :)
Patent 5686355: Method for forming film of refractory metal
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Plural layered electrode or conductor : Having adhesion promoting layer : Having noble group metal (i.e., silver (Ag), gold (Au), platinum (Pt), palladium (Pd), rhodium (Rh), ruthenium (Ru), iridium (Ir), osmium (Os), or alloy thereof))
Patent 5686356: Conductor reticulation for improved device planarity
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Multiple metal levels, separated by insulating layer (i.e., multiple level metallization) : Separating insulating layer is laminate or composite of plural insulating materials : By wire bonding)
Patent 5686357: Method for forming a contact during the formation of a semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Multiple metal levels, separated by insulating layer (i.e., multiple level metallization) : With formation of opening (i.e., viahole) in insulative layer : Having viahole with sidewall component : Silicide formation)
Patent 5686358: Method for forming a plug in a semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Forming contacts of differing depths into semiconductor substrate : Including fusion of conductor)
Patent 5686359: Titanium silicide process
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Including heat treatment of conductive layer : Rapid thermal anneal : Forming silicide : Silicide)
Patent 5686360: Passivation of organic devices
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING DEVICE OR CIRCUIT EMISSIVE OF NONELECTRICAL SIGNAL : Packaging (e.g., with mounting, encapsulating, etc.) or treatment of packaged semiconductor : Plural emissive devices : Packaging (e.g., with mounting, encapsulating, etc.) or treatment of packaged semiconductor)
Patent 5686361: Method for manufacturing a semiconductor device having a heat radiator
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : PACKAGING (E.G., WITH MOUNTING, ENCAPSULATING, ETC.) OR TREATMENT OF PACKAGED SEMICONDUCTOR : Including adhesive bonding step : Substrate dicing)
Patent 5686362: Method of manufacturing a semiconductor integrated circuit device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : PACKAGING (E.G., WITH MOUNTING, ENCAPSULATING, ETC.) OR TREATMENT OF PACKAGED SEMICONDUCTOR : Making plural separate devices : Substrate dicing : And encapsulating)
Patent 5686363: Controlled taper etching
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Combined with coating step : Simultaneous etching and coating : Simultaneous (e.g., chemical-mechanical polishing, etc.))
Patent 5686364: Method for producing substrate to achieve semiconductor integrated circuits
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Total dielectric isolation : Bonding of plural semiconductive substrates : Multiple doping steps)
Patent 5686365: Method for dissolution and stabilization of silica-rich fibers
(COMPOSITIONS: CERAMIC : CERAMIC COMPOSITIONS : Glass compositions, compositions containing glass other than those wherein glass is a bonding agent, or glass batch forming compositions : Pore-forming : Titanium or zirconium containing)
Patent 5686366: Process for producing platelet .alpha.-Al.sub.2 O.sub.3 based ceramic composite
(COMPOSITIONS: CERAMIC : CERAMIC COMPOSITIONS : Refractory : Trivalent metal compound (e.g., iron oxide, chromium oxide, trivalent rare earth oxide, etc.) containing : Aluminum compound (e.g., clay, aluminium oxide, etc.) : Aluminum compound other than clay)
Patent 5686367: Semiconducting ceramic composition having positive temperature coefficient of resistance and production process thereof
(COMPOSITIONS: CERAMIC : CERAMIC COMPOSITIONS : Titanate, zirconate, stannate, niobate, or tantalate or oxide of titanium, zirconium, tin, niobium, or tantalum containing (e.g., dielectrics, etc.) : Alkaline earth or magnesium containing : Titanate containing : Barium titanate : And clay containing)
Patent 5686368: Fibrous metal oxide textiles for spectral emitters
(COMPOSITIONS: CERAMIC : CERAMIC COMPOSITIONS : Yttrium, lanthanide, actinide, or transactinide containing (i.e., atomic numbers 39 or 57-71 or 89+) : Clay pretreatment)
Patent 5686369: Method and apparatus for treating dehydrogenation catalysts
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : REGENERATING OR REHABILITATING CATALYST OR SORBENT : Treating with a liquid or treating in a liquid phase, including dissolved or suspended : Using salt or alkaline substance :)
Patent 5686370: Zeolite catalyst with chromium for the production of gasolines with low aromatic content and high octane number
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : ZEOLITE OR CLAY, INCLUDING GALLIUM ANALOGS : ZSM type : Mixed clays)
Patent 5686371: Conjugated diene polymerisation
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Plural component system comprising A - Group I to IV metal hydride or organometallic compound - and B - Group IV to VIII metal, lanthanide or actinde compound - (i.e., alkali metal, Ag, Au, Cu, alkaline earth metal, Be, Mg, Zn, Cd, Hg, Sc, Y, Al, Ga, In, Tl, Ti, Zn, Hf, Ge, Sn or Pb hydride or organometallic compound and Ti, Zr, Hf, Ge, Sn, Pb, V, Nb, Ta, As, Sb, Bi, Cr, Mo, W, Po, Mn, Tc, Re, Iron group, Platinum group, atomic number 57 to 71 inclusive or atomic number 89 or higher compound) : Utilizing ammonium ions)
Patent 5686372: Photocatalyst with modified alkyl silicate ester support and process for production thereof
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Silicon containing or process of making : With metal, metal oxide, or metal hydroxide : Of Group IV (i.e., Ti, Zr, Hf, Ge, Sn or Pb) : Of Group IV metal (i.e., Ti, Zr, Hf, Ge, Sn or Pb))
Patent 5686373: Polymetal oxide materials
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Metal, metal oxide or metal hydroxide : Of Group VI (i.e., Cr, Mo, W or Po) : And Group V metal containing (i.e., V, Nb, Ta, As, Sb or Bi) : Vanadium containing : Platinum or palladium)
Patent 5686374: Catalyst for hydroprocessing
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Metal, metal oxide or metal hydroxide : Of Group VI (i.e., Cr, Mo, W or Po) : And Group VIII metal containing (i.e., iron or platinum group) : Vanadium containing)
Patent 5686375: Hydroprocessing catalyst and its use
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Metal, metal oxide or metal hydroxide : Of Group VI (i.e., Cr, Mo, W or Po) : And Group VIII metal containing (i.e., iron or platinum group) : Nickel containing : Platinum or palladium)
Patent 5686376: Chelating agents for improved color fidelity
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Metal, metal oxide or metal hydroxide : Of Group VIII (i.e., iron or platinum group) : And Group II metal containing (i.e., alkaline earth, Be, Mg, Zn, Cd or Hg) : Zinc containing : Platinum or palladium)
Patent 5686377: Catalyst for purifying exhaust gases
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Metal, metal oxide or metal hydroxide : Of Group VIII (i.e., iron or platinum group) : And Group I metal containing (i.e., alkali, Ag, Au or Cu) : Zinc containing)
Patent 5686378: Lamella lepidocrocite particles and process for producing the same
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Metal, metal oxide or metal hydroxide : Of Group VIII (i.e., iron or platinum group) : Of iron : Of iron)
Patent 5686379: Alkoxylation catalyst, process for the preparation of the catalyst and process for preparing alkoxylate with the use of the catalyst
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Metal, metal oxide or metal hydroxide : Of Group II (i.e., alkaline earth, Be, Mg, Zn, Cd or Hg) : Of palladium or platinum)
Patent 5686380: Vapor phase oxidation of propylene to propylene oxide
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Metal, metal oxide or metal hydroxide : Of Group I (i.e., alkali, Ag, Au or Cu) : Of silver : And Group III metal containing (i.e., Sc, Y, Al, Ga, In or Tl))
Patent 5686381: Mixed V/Sb/Sn oxide ammoxidation catalysts
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Metal, metal oxide or metal hydroxide : Of Group IV (i.e., Ti, Zr, Hf, Ge, Sn or Pb) : Of tin : And Group III metal containing (i.e., Sc, Y, Al, Ga, In or Tl))
Patent 5686382: Thermal recording structure and method
(RECORD RECEIVER HAVING PLURAL INTERACTIVE LEAVES OR A COLORLESS COLOR FORMER, METHOD OF USE, OR DEVELOPER THEREFOR : HAVING A COLORLESS COLOR-FORMER, DEVELOPER THEREFOR, OR METHOD OF USE : Method of use, kit, or combined with marking instrument or organ :)
Patent 5686383: Method of making a color filter array by colorant transfer and lamination
(RECORD RECEIVER HAVING PLURAL INTERACTIVE LEAVES OR A COLORLESS COLOR FORMER, METHOD OF USE, OR DEVELOPER THEREFOR : HAVING PLURAL INTERACTIVE LEAVES : Spatial relationship specified between color-former and developer)
Patent 5686384: Compatibility agent and method
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Designated nonactive ingredient containing : Liquid carrier containing (e.g., water, hydrocarbon, etc.) : Emulsion or foam (i.e., liquid continuous phase, and liquid or gas discontinuous phase) : Oximes (i.e., HCN=N-OH, wherein substitution may be made for hydrogen only))
Patent 5686385: Agricultural microcapsule and production thereof
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Designated nonactive ingredient containing : Microencapsulating or encapsulating agent : Benzene ring containing)
Patent 5686386: Herbicidal composition and weeding method
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Plural active ingredients : Phosphorus containing active ingredient wherein the phosphorus is other than solely as part of an inorganic ion in an addition salt : With an active heterocyclic compound : Containing -C(=X)X- or -C(=X)NH-, wherein the X`s are the same or diverse chalcogens and substitution may be made for hydrogen only (e.g., phenoxyacetic acids, ureas, etc.))
Patent 5686387: Compositions containing semicarbazones
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Plural active ingredients : Hetero ring containing active ingredient : Hetero ring is six-membered including nitrogen : Containing -C(=X)X- or -C(=X)NH-, wherein the X`s are the same or diverse chalcogens and substitution may be made for hydrogen only (e.g., phenoxyacetic acids, ureas, etc.))
Patent 5686388: Concentrated stable suspension of herbicidally active 1,3,5-triazines and pyridate
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Plural active ingredients : Hetero ring containing active ingredient : Hetero ring is six-membered including nitrogen : The hetero ring consists of three nitrogens and three carbons : With additional hetero ring active ingredient :)
Patent 5686389: Growth inhibition of Erwinia amylovora
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Plural active ingredients : Active ingredient contains -C(=X)X-, wherein the X`s are the same or diverse chalcogens : Nitrogen or halogen attached indirectly to the carbon of the -C(=X)X- group by acyclic nonionic bonding : With an active ingredient containing nitrogen, other than as nitro or nitroso, wherein the nitrogen is attached directly or indirectly to carbon by nonionic bonding)
Patent 5686390: Iminosulfonylurea derivatives and herbicides
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Organic active compound containing : Hetero ring containing : Acyclic urea or thiourea bonded directly to ring carbon of the hetero ring (i.e., HNH-C(=X)-NH-, wherein X is sulfur or oxygen and substitution may be made for hydrogen only) : Sulfonyl bonded directly to the urea or thiourea nitrogen (e.g., N-phenylsulfonyl-N`- pyridinylureas, etc.) : The hetero ring consists of three nitrogens and three carbons : Additional hetero ring containing :)
Patent 5686391: Sarcosinates as fluazifop-butyl adjuvants and activators
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Organic active compound containing : Hetero ring containing : Hetero ring is six-membered consisting of one nitrogen and five carbons : Chalcogen bonded directly to ring carbon of the six-membered hetero ring : Benzene ring bonded directly to the chalcogen : Containing -C(=X)X-, wherein the X`s are the same or diverse chalcogens :)
Patent 5686392: Process for preparing substituted N-carbamoyl-Tetrazolinones
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Organic active compound containing : Hetero ring containing : Hetero ring is five-membered having two or more ring hetero atoms of which at least one is nitrogen : Nitrogen, other than as nitro or nitroso, or -C(=X)-, wherein X is chalcogen, bonded directly to ring carbon of the six-membered hetero ring)
Patent 5686393: Arthropodicidal oxazolines and thiazolines
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Organic active compound containing : Hetero ring containing : Hetero ring is five-membered having two or more ring hetero atoms of which at least one is nitrogen : 1,3-oxazoles (including hydrogenated) : Benzothiazoles (including hydrogenated))
Patent 5686394: Process for manufacturing a superconducting composite
(SUPERCONDUCTOR TECHNOLOGY: APPARATUS, MATERIAL, PROCESS : PROCESSES OF PRODUCING OR TREATING HIGH TEMPERATURE (TC GREATER THAN 30 K) SUPERCONDUCTOR MATERIAL OR SUPERCONDUCTOR CONTAINING PRODUCTS OR PRECURSORS THEREOF : Process of making wire, tape, cable, coil, or fiber : With metal deforming, metal wrapping, or metal coiling :)
Patent 5686396: Efficiency of polyglycerol with other additives to remove water from shale
(EARTH BORING, WELL TREATING, AND OIL FIELD CHEMISTRY : EARTH BORING : Contains organic component : Organic component contains ether linkage (e.g., PEG ether, etc.) : Organic component contains a sulfur attached directly to carbon by nonionic bonding (e.g., sulfonate, etc.))
Patent 5686397: Dithiocarbamate derivatives and lubricants containing same
(SOLID ANTI-FRICTION DEVICES, MATERIALS THEREFOR, LUBRICANT OR SEPARANT COMPOSITIONS FOR MOVING SOLID SURFACES, AND MISCELLANEOUS MINERAL OIL COMPOSITIONS : LUBRICANTS OR SEPARANTS FOR MOVING SOLID SURFACES AND MISCELLANEOUS MINERAL OIL COMPOSITIONS (E.G., WATER CONTAINING, ETC.) : Heterocyclic ring compound; a heterocyclic ring is one having as ring members only carbon and at least one hetero atom selected from nitrogen and chalcogen (i.e., oxygen, sulfur, selenium, or tellurium) : The hetero ring contains five members including nitrogen and carbon (e.g., polyvinylpyrrolidone, etc.) : Plural hetero atoms in the hetero ring (e.g., pyrazoles, benzimidazoles, etc.) : Chalcogen in the hetero ring (e.g., benzoxazoles, etc.) : The chalcogen is sulfur (e.g., 1,3-thiazole,etc.) : Plural nitrogens or plural sulfurs in the hetero ring (e.g., thiadiazoles, etc.) : Acyclic sulfur bonded directly to the 2- and 5- positions of a 1,3,4- thiadiazole ring or a hydrogenated 1,3,4-thiadiazole ring : Oxygen or nitrogen attached indirectly to one of the acyclic sulfurs by acyclic nonionic bonding :)
Patent 5686398: Additive for lubricant or fuel, lubricating oil composition or fuel composition containing it, and substituted hydroxyaromatic ester
(SOLID ANTI-FRICTION DEVICES, MATERIALS THEREFOR, LUBRICANT OR SEPARANT COMPOSITIONS FOR MOVING SOLID SURFACES, AND MISCELLANEOUS MINERAL OIL COMPOSITIONS : LUBRICANTS OR SEPARANTS FOR MOVING SOLID SURFACES AND MISCELLANEOUS MINERAL OIL COMPOSITIONS (E.G., WATER CONTAINING, ETC.) : Organic -C(=O)O- compound : Specified compound wherein the single bonded oxygen is bonded oxygen is bonded directly to an additional carbon, which carbon may be single bonded to any atom but may be multiple bonded only to carbon (i.e., specified carboxylic acid ester) : Plural -C(=O)O- groups attached directly or indirectly to each other by nonionic bonding (e.g., estolides of hydroxy carboxylic acids, etc.) : Benzene ring attached directly or indirectly to the -C(=O)O- groups by nonionic bonding : The benzene ring is bonded directly to carbon of a -C(=O)O- group : Carbons of plural -C(=O)O- groups are bonded directly to the same benzene ring (e.g., vanadium salt of oleyl acid phthalate,etc.) : Three or more -C(=O)O- groups attached indirectly to each other by nonionic bonding : Oxygen or nitrogen attached indirectly to one of the acyclic sulfurs by acyclic nonionic bonding)
Patent 5686399: Limescale removal compositions
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : For cleaning a specific substrate or removing a specific contaminant (e.g., for smoker`s pipe, etc.) : For toilet bowl or urinal : Phenol, cyclic carbonate, or soap component)
Patent 5686400: Manual dishwashing method using betaine-anionic surfactant mixtures
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : For cleaning a specific substrate or removing a specific contaminant (e.g., for smoker`s pipe, etc.) : For equipment used in processing, handling, storing, or serving edible product (e.g., dairy or brewery equipment, household utensils, etc.) : For manual dishwashing : Carboxamide, amine oxide, heterocyclic, quaternary, or zwitterion nitrogen-containing component : With inorganic silicon containing component)
Patent 5686401: Bleaching compounds comprising N-acyl caprolactam for use in hand-wash or other low-water cleaning systems
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : For cleaning a specific substrate or removing a specific contaminant (e.g., for smoker`s pipe, etc.) : For textile material (e.g., laundry detergent, etc.) : With oxygen or halogen containing chemical bleach or oxidant component : Peroxy component : With nitrogen or oxygen containing bleach precursor or activator (e.g., ester, acid anhydride, etc.) : Carbonyl single bonded to nitrogen in the activator or precursor (e.g., amide, imide, etc.) :)
Patent 5686402: Detergent compositions containing ethylene dicysteate (EDC) sequestrants
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : For cleaning a specific substrate or removing a specific contaminant (e.g., for smoker`s pipe, etc.) : For textile material (e.g., laundry detergent, etc.) : Polycarboxylic acid component, or acid anhydride or salt thereof (e.g., sodium citrate, maleic anhydride polymer, polyacrylic acid, etc.) : With inorganic phosphorus containing component)
Patent 5686403: Cleanser composition containing phosphate ester and ether acetate surfactants
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : Liquid composition : Organic phosphorus containing component : Organic solvent component)
Patent 5686404: Suds controlling compositions
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : Specific organic component (e.g., triazines, etc.) : Silicon in the component : Soap component)
Patent 5686405: Method of fixing a perfume in a cosmetic and/or dermatological composition with a plant compound
(PERFUME COMPOSITIONS : PERFUME COMPOSITIONS : With preservative, stabilizer, or fixative (e.g., retarding evaporation) :)
Patent 5686406: Vanillic acid ester perfuming agents
(PERFUME COMPOSITIONS : PERFUME COMPOSITIONS : Ring containing active ingredient : Benzene ring : Acyclic carbonyl containing : The ring system is bicyclo)
Patent 5686407: Hepatocyte growth factor to treat glaucoma
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI :)
Patent 5686408: Method for modifying, diagnosing, and screening for IGF-I sensitive cell barrier properties
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : Insulin or derivative :)
Patent 5686409: Antirestenosis protein
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)
Patent 5686410: Polypeptide derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)
Patent 5686411: Amylin agonist peptides and uses therefor
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)
Patent 5686412: Protein kinases
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)
Patent 5686413: Ractopamine and growth hormone combinations
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)
Patent 5686414: Methods of treating conditions associated with corneal transplantation
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)
Patent 5686415: Method for the treatment of colon epithelial cells in vivo
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)
Patent 5686416: Increasing blood-brain barrier permeability with permeabilizer peptides
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 9 to 11 peptide repeating units in known peptide chain : Monocyclic)
Patent 5686417: Peptide T and related peptides in the treatment of HTLV-1 myelopathy and multiple sclerosis
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 7 or 8 peptide repeating units in known peptide chain : Monocyclic)
Patent 5686418: Prolonging survival of transplanted pancreatic cells
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 5 or 6 peptide repeating units in known peptide chain : Monocyclic)
Patent 5686419: Basic .alpha.-aminoalkylphosphonate derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 3 or 4 peptide repeating units in known peptide chain : Monocyclic)
Patent 5686420: Thyrotropin-releasing hormone analogs and method of use
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 3 or 4 peptide repeating units in known peptide chain : Monocyclic)
Patent 5686421: Hydantoin derivates
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 3 or 4 peptide repeating units in known peptide chain : Monocyclic)
Patent 5686422: Synthetic inhibitors of mammalian collagenase
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 3 or 4 peptide repeating units in known peptide chain : Monocyclic)
Patent 5686423: Di-and tri-peptide mimetic compounds for Parkinson's disease
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 3 or 4 peptide repeating units in known peptide chain : Monocyclic)
Patent 5686424: 2-oxoethyl derivatives as immunosuppressants
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 2 peptide repeating units in known peptide chain : Monocyclic)
Patent 5686425: Composition and method for revitalizing scar tissue
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : Produced by or extracted from animal tissue : Guanidine containing)
Patent 5686426: Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : O-glycoside : Guanidine containing)
Patent 5686428: Pharmaceutical composition
(PACKAGE MAKING : METHODS : Conforming by stretching or shrinking of cover over contents : Heating or cooling)
Patent 5686429: Method for providing nutrition to elderly patients
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : N-glycoside : Nitrogen containing hetero ring : Phosphorus containing (e.g., Vitamin B12, etc.) : 2,4-diketone pyrimidine or derivative (e.g., uracil, etc.))
Patent 5686431: Methods of using low molecular weight heparins for treatment of pathological processes
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : Polysaccharide : Heparin or derivative : Phosphorus containing (e.g., Vitamin B12, etc.))
Patent 5686432: Use of some glycosaminoglycans in the peritoneal dialysis
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : Polysaccharide : Heparin or derivative : Phosphorus containing (e.g., Vitamin B12, etc.))
Patent 5686433: Quinoline and pyridine anchors for HMG-CoA reductase inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Phosphorus containing other than solely as part of an inorganic ion in an addition salt DOAI : Nitrogen containing hetero ring : Polycylo ring system having a ring nitrogen in the system : Phosphorus containing (e.g., Vitamin B12, etc.))
Patent 5686434: 3-aryl-2-isoxazolines as antiinflammatory agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Phosphorus containing other than solely as part of an inorganic ion in an addition salt DOAI : Nitrogen containing hetero ring : Hetero ring is five-membered : Two or more hetero atoms in the five-membered ring : Two or more PX- groups attached to the same 1,3-diazine (X is chalcogen))
Patent 5686435: Vitamin D amide derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : 9,10-seco- cyclopentanohydrophenanthrene ring system (e.g., vitamin D, etc.) DOAI : Nitrogen containing (e.g., anilides, etc.))
Patent 5686436: Multi-faceted method to repress reproduction of latent viruses in humans and animals
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Cyclopentanohydrophenanthrene ring system DOAI : With additional active ingredient : The hetero ring is five-membered)
Patent 5686437: Estrogen nucleus derivatives for use in the inhibition of sex steroid activity
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Cyclopentanohydrophenanthrene ring system DOAI : Hetero ring containing : The hetero ring is five-membered)
Patent 5686438: Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Cyclopentanohydrophenanthrene ring system DOAI : Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system : Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system : One benzene ring bonded directly to chalcogen)
Patent 5686439: Chelate complexes and processes for their preparation
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Heavy metal containing (including salts) : Polycyclo ring system : 21-position substituted)
Patent 5686440: Aqueous 6-›3-(3,4-dimethoxybenzyl)-amino-2-hydroxypropoxy! carbostyril composition
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Heavy metal containing (including salts) : Polycyclo ring system : Bicyclo ring system : Quinolines or isoquinolines (including hydrogenated) : Phosphorus containing)
Patent 5686441: Penam sulfones as .beta.-lactamase inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : 1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) : 3-position substituent contains -COOC- group : Bicyclo ring system)
Patent 5686442: Tricyclic benzazepine and benzothiazepine derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring contains seven members including nitrogen, carbon and chalcogen : Chalcogen double bonded directly to a ring carbon which is adjacent to the ring nitrogen : Polycyclo ring system which contains the seven-membered hetero ring as one of the cyclos : Polycyclo ring system having the additional hetero ring as one of the cyclos)
Patent 5686444: Selected soluble esters of hydroxyl-containing indolocarbazoles
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring contains seven members including nitrogen, carbon and chalcogen : Plural ring nitrogens in the seven-membered hetero ring : Polycyclo ring system which contains the seven-membered hetero ring as one of the cyclos)
Patent 5686445: Pyridobenzoxazepine and pyridobenzothiazepine vasopressin antagonists
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring contains seven members including nitrogen, carbon and chalcogen : Polycyclo ring system which contains the seven-membered hetero ring as one of the cyclos : Three ring hetero atoms in the polycyclo ring system : Bicyclo ring system having the seven-membered hetero ring as one of the cyclos)
Patent 5686446: Aminoalkyloximes
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring contains seven members including nitrogen, carbon and chalcogen : Additional nitrogen containing hetero ring attached directly or indirectly to the seven-membered hetero ring by nonionic bonding : Tricyclo ring system having the seven-mmbered hetero ring as one of the cyclos)
Patent 5686447: Aminoalkyloximes for treating depression and affective disorders
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system)
Patent 5686448: Treatment of virus infections with ganglionic blocking agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is seven-membered consisting of one nitrogen and six carbons : Polycyclo ring system having the seven-membered hetero ring as one of the cyclos : Two of the cyclos share at least three ring carbons (i.e., bridged) : Two of the cyclos share at least three ring members (i.e., bridged))
Patent 5686449: 1,5-benzodiazepines useful as gastrinor CCK-antagonists
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms : Polycyclo ring system having the seven-membered hetero ring as one of the cyclos : Bicyclo ring system having the seven-membered hetero ring as one of the cyclos : Plural ring hetero atoms in the additional hetero ring)
Patent 5686450: Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members : Three or more ring hetero atoms in the six-membered hetero ring : Bicyclo ring system having the seven-membered hetero ring as one of the cyclos)
Patent 5686451: Combination of an ace inhibitor and a diuretic
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members : Three or more ring hetero atoms in the six-membered hetero ring : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : 1,2,4 - Benzothiadiazine - 1,1 - dioxides (including hydrogenated) : With additional active ingredient : Nitrogen attached directly or indirectly to the ring nitrogen of the seven-membered hetero ring by acyclic nonionic bonding (e.g., Diltiazem, etc.))
Patent 5686452: Indane derivative and processes for preparing the same
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : Polycyclo ring system having a 1,3,5-triazine as one of the cyclos)
Patent 5686454: Camphorcarbonyl
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,4 diazines : Piperazines (i.e., fully hydrogenated 1,4-diazines) : Additional hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding : The additional hetero ring is five-membered having ring nitrogen : Plural nitrogens in the additional five-membered hetero ring : The additional five-membered hetero ring consists of three ring carbons, and of nitrogen and chalcogen in adjacent ring positions (e.g., isoxazolyl, isothiazolyl, etc.))
Patent 5686455: Imidazole derivatives and their use as cytokine inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,3-diazines (e.g., pyrimidines, etc.) : Nitrogen or -C(=X)-, wherein X is chalcogen, bonded directly to ring carbon of the 1,4-diazine ring)
Patent 5686456: Methods of treating pneumocystis carinii pneumonia
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,3-diazines (e.g., pyrimidines, etc.) : Nitrogen or -C(=X)-, wherein X is chalcogen, bonded directly to ring carbon of the 1,4-diazine ring)
Patent 5686457: Pyrrolopyrimidine derivatives having pharmacological activity
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,3-diazines (e.g., pyrimidines, etc.) : Polycyclo ring system having 1,3-diazine as one of the cyclos : Bicyclo ring system having the 1,3-diazine as one of the cyclos : The other cyclo in the bicyclo ring system is a pyrrole ring (including hydrogenated) (e.g., pyrrolo[3,2-d]pyrimidine, etc.) : Nitrogen bonded directly to ring carbon of the 1,3-diazine ring of the bicyclo ring system)
Patent 5686458: Quinazoline deriviates for treating peptic ulcer
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,3-diazines (e.g., pyrimidines, etc.) : Polycyclo ring system having 1,3-diazine as one of the cyclos : Bicyclo ring system having the 1,3-diazine as one of the cyclos : Quinazoline (including hydrogenated)(i.e., the second cyclo in the bicyclo ring system is an ortho-fused six-membered carbocycle) : Additional hetero ring attached directly or indirectly to the quinazoline ring system by nonionic bonding : The additional hetero ring is six-membered consisting of one nitrogen and five carbons : Nitrogen bonded directly to a ring carbon of the purine ring system (e.g., guanine, etc.))
Patent 5686459: Dioxopyrrolo pyrrole derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,3-diazines (e.g., pyrimidines, etc.) : Polycyclo ring system having 1,3-diazine as one of the cyclos : Bicyclo ring system having the 1,3-diazine as one of the cyclos : Quinazoline (including hydrogenated)(i.e., the second cyclo in the bicyclo ring system is an ortho-fused six-membered carbocycle) : Additional hetero ring attached directly or indirectly to the quinazoline ring system by nonionic bonding : Nitrogen bonded directly to ring carbon of the purine ring system (e.g., adenine, etc.))
Patent 5686460: Carbocyclic diarylmethylene derivatives, processes for their preparation and their uses in therapeutics
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : 1,3-diazines (e.g., pyrimidines, etc.))
Patent 5686461: Indole derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Spiro ring system : Thiamines (e.g., vitamin B1, etc.))
Patent 5686462: Anti-inflammatory method
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Tricyclo ring system having the six-membered hetero ring as one of the cyclos : Plural hetero atoms in the tricyclo ring system : Plural ring nitrogens in the tricyclo ring system : Nitrogen bonded directly to ring carbon of the 1,3-diazine ring of the quinazoline ring system)
Patent 5686463: Oxadiazoles useful in the treatment of senile dementia
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Bicyclo ring system having the six-membered hetero ring as one of the cyclos : Phenanthridines (including hydrogenated))
Patent 5686464: 3,3-diphenylpropylamines, their use and preparation
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Bicyclo ring system having the six-membered hetero ring as one of the cyclos)
Patent 5686465: Sex steroid activity inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : The additional ring is one of the cyclos in a polycyclo ring system : Hetero ring in the polycyclo ring system : Three or more hetero atoms in the tricyclo ring system)
Patent 5686466: Tricyclic condensed heterocyclic compounds their production and use
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : The additional ring is one of the cyclos in a polycyclo ring system : Hetero ring in the polycyclo ring system : Ring nitrogen in the polycyclo ring system : Plural ring nitrogens in the polycyclo ring system)
Patent 5686467: Methods of inhibiting imperfect tissue repair
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : The additional ring is one of the cyclos in a polycyclo ring system : Hetero ring in the polycyclo ring system : Ring sulfur in the polycyclo ring system : Plural ring nitrogens in the polycyclo ring system)
Patent 5686468: Methods of inhibiting hirsutism and alopecia in women
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : The additional ring is one of the cyclos in a polycyclo ring system : Hetero ring in the polycyclo ring system : Ring sulfur in the polycyclo ring system : Plural ring nitrogens in the polycyclo ring system)
Patent 5686469: Aminomethylene derivaties as immunosuppressants
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : C=X bonded directly to the piperidine ring (X is chalcogen) : Plural chalcogens bonded directly to ring carbons of the piperidine ring)
Patent 5686470: 2, 3-substituted pyridines for the treatment of inflammation
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Plural six-membered hetero rings consisting of one nitrogen and five carbon atoms : The six-membered hetero rings are bonded directly to each other : Nitrogen attached indirectly to the piperidine ring by nonionic bonding)
Patent 5686471: Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Additional hetero ring containing : The additional hetero ring is one of the cyclos in a polycyclo ring system : Nitrogen attached indirectly to the piperidine ring by nonionic bonding)
Patent 5686472: Inhibitors of farnesyl-protein transferase
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Nitrogen attached indirectly to the six-membered hetero ring by nonionic bonding : At 3-position)
Patent 5686473: Substituted pyridines useful as modulators of acetylcholine receptors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Nitrogen attached indirectly to the six-membered hetero ring by nonionic bonding : At 3-position)
Patent 5686474: Acetylene derivatives and crop protection agents containing them
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : Plural ring nitrogens and a single chalcogen in the hetero ring : 1,3,4-thiadiazoles (including hydrogenated) : C=O in a C(=O)O group (e.g., nicotinic acid, etc.))
Patent 5686475: Application of riluzole in the treatment of mitochondrial diseases
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,3-thiazoles (including hydrogenated) : Polycyclo ring system having the thiazole ring as one of the cyclos : Bicyclo ring system having the thiazole ring as one of the cyclos : Plural chalcogens bonded directly to ring carbons of the piperidine ring)
Patent 5686476: Methods of inhibiting Alzheimer's Disease
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : The additional ring is one of the cyclos in a polycyclo ring system : Hetero ring in the polycyclo ring system : Ring sulfur in the polycyclo ring system : Plural ring nitrogens in the polycyclo ring system)
Patent 5686477: 5-(arloxymethyl)oxazolines
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,3-oxazoles (including hydrogenated) : Nitrogen bonded directly to ring carbon of the oxazole ring : C=X bonded directly to the nitrogen which is bonded directly to the thiazole ring (X is chalcogen))
Patent 5686478: Endothelin antagonists
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : Tetrazoles (including hydrogenated) : Additional chalcogen containing hetero ring : C=X bonded directly to the nitrogen which is bonded directly to the thiazole ring (X is chalcogen))
Patent 5686479: Immunosuppressive drug
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,2,4-triazoles (including hydrogenated) : Additional chalcogen containing hetero ring)
Patent 5686480: Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,2-diazoles : 2-imidazolines)
Patent 5686481: Endothelin receptor antagonists
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : The five-membered hetero ring consists of one nitrogen and four carbons : Polycyclo ring system having the five-membered hetero ring as one of the cyclos : Bicyclo ring system having the five-membered hetero ring as one of the cyclos : Additional hetero ring which is not part of the bicyclo ring system : Ring sulfur in the polycyclo ring system)
Patent 5686482: N-(3-pyrrolidinyl) benzamide derivative
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : The five-membered hetero ring consists of one nitrogen and four carbons : Nitrogen bonded directly to the five-membered hetero ring by nonionic bonding : Plural chalcogens bonded directly to the five-membered hetero ring by nonionic bonding)
Patent 5686483: Aminoalkyloximes
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : The five-membered hetero ring consists of one nitrogen and four carbons : Chalcogen bonded indirectly to the five-membered hetero ring by acyclic nonionic bonding : Plural chalcogens bonded directly to the five-membered hetero ring by nonionic bonding)
Patent 5686484: Milbemycin derivatives, their preparation and their use
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Oxygen containing hetero ring : The hetero ring has at least seven members : C=O bonded directly to the hetero ring (X is chalcogen))
Patent 5686485: Physiologically active EI-1941 compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Oxygen containing hetero ring : The hetero ring is six-membered : Polycyclo ring system having the hetero ring as one of the cyclos : Tricyclo ring system having the hetero ring as one of the cyclos : Nitrogen bonded directly to the hetero ring by nonionic bonding)
Patent 5686486: 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl›b!pyran-2-ones useful to treat retroviral infections
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Oxygen containing hetero ring : The hetero ring is six-membered : Polycyclo ring system having the hetero ring as one of the cyclos : Bicyclo ring system having the hetero ring as one of the cyclos (e.g., chromones, etc.) : Chalcogen bonded directly to ring carbon of the hetero ring)
Patent 5686487: Treatment of cataract with 15-keto-prostaglandin compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Ester DOAI : Z-C(=O)-O-Y wherein Z is hydrogen or an organic radical bonded to the C(=O) by a carbon and Y is an organic radical bonded to the oxygen by a carbon : Z contains a cyclopentyl or cyclopentene ring : C=O other than as ketone or aldehyde)
Patent 5686488: Polyethoxylated castor oil products as anti-inflammatory agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Ester DOAI : Z-C(=O)-O-Y wherein Z is hydrogen or an organic radical bonded to the C(=O) by a carbon and Y is an organic radical bonded to the oxygen by a carbon : ZC(=O)OY, wherein Z is an acyclic radical bonded to the C=O by a carbon and Y is an organic radical bonded to the oxygen by a carbon : Z radical contains carbon to carbon unsaturation : Ring is alcohol moiety)
Patent 5686489: Alpha hydroxyacid esters for skin aging
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Benzene ring in acid moiety)
Patent 5686490: Method for breeding infant livestock and feed composition
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Higher fatty acid or salt thereof : Z contains an unbroken chain of at least seven carbon atoms bonded directly to the C(=O) group)
Patent 5686491: Infant formula
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Nitrogen other than as nitro or nitroso nonionically bonded : Carbon to carbon unsaturation)
Patent 5686492: Disubstituted p-fluorobenzenesulfonamides
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Nitrogen other than as nitro or nitroso nonionically bonded : Sulfur nonionically bonded : Ring is alcohol moiety)
Patent 5686493: Method for protecting against endotoxin-induced shock using ornithine
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Nitrogen other than as nitro or nitroso nonionically bonded : Plural nitrogens nonionically bonded : N-N or N=C(-N)-N containing (e.g., hydrazines, hydrazones, or quanidines, etc.) : Z radical contains two or more nitrogen atoms at least one of which forms a C(=X)N group (X is chalcogen))
Patent 5686494: Pharmaceutical preparations for ameliorating epigastric functional disorders
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI : Carboxamides (i.e., R-C(=O)-N, wherein R is a radical having carbon bonded directly to the C(=O)-N or is hydrogen and wherein any substituent attached to nitrogen will be referred to as E) : Plural carboxamide groups or plural C=O groups bonded directly to the same nitrogen : R contains benzene ring)
Patent 5686495: Substituted hydrazinedicarboximidamides and methods of use thereof
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI : Amidines (i.e., N=C-N) : Amidino hydrazines or hydrazones (i.e., N-N=C-N or N=C-N-N) : R is hydrogen or a lower saturated alkyl of less than seven carbons)
Patent 5686496: Chemical compound, the preparation thereof and its use in pharmaceutical compositions
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI : Amidines (i.e., N=C-N) : Benzene ring containing : Biguanides (i.e., N=C(-N)-N(N-)C=N))
Patent 5686497: Expandable beads based on a polymer of a vinylaromatic compound containing blowing agent and plasticizer
(SYNTHETIC RESINS OR NATURAL RUBBERS -- PART OF THE CLASS 520 SERIES : : CELLULAR PRODUCTS OR PROCESSES OF PREPARING A CELLULAR PRODUCT, E.G., FOAMS, PORES, CHANNELS, ETC. : Particle which is expandible, process of preparing an expandible particle, or process of expanding a particle to form a cellular product : Treating a cellular solid polymer by adding a material thereto which forms a composition therewith)
Patent 5686499: Polyurethane foams containing high levels of silicone-containing surfactant polymer to improve flame retardance and aged K-factors
(SYNTHETIC RESINS OR NATURAL RUBBERS -- PART OF THE CLASS 520 SERIES : : CELLULAR PRODUCTS OR PROCESSES OF PREPARING A CELLULAR PRODUCT, E.G., FOAMS, PORES, CHANNELS, ETC. : Cellular product formation prior to or during solid polymer formation in the presence of a stated ingredient other than water : Ingredient contains a silicon atom as part an organic compound : Organic silicon compound contains an ether group : Organic phosphorus compound contains a phosphorus atom bonded to an atom other than oxygen)
Patent 5686500: Polyol composition having good flow and water blown rigid polyurethane foams made thereby having good dimensional stability
(SYNTHETIC RESINS OR NATURAL RUBBERS -- PART OF THE CLASS 520 SERIES : : CELLULAR PRODUCTS OR PROCESSES OF PREPARING A CELLULAR PRODUCT, E.G., FOAMS, PORES, CHANNELS, ETC. : Cellular product formation prior to or during solid polymer formation in the presence of a stated ingredient other than water : Ingredient is a nitrogen containing compound : Nitrogen compound contains a nitrogen atom bonded to three carbon atoms and wherein none of the carbon atoms are double-bonded to oxygen : Organic metal compound contains tin)
Patent 5686501: Breathable open cell urethane polymers
(SYNTHETIC RESINS OR NATURAL RUBBERS -- PART OF THE CLASS 520 SERIES : : CELLULAR PRODUCTS OR PROCESSES OF PREPARING A CELLULAR PRODUCT, E.G., FOAMS, PORES, CHANNELS, ETC. : Cellular product formation prior to or during solid polymer formation in the presence of a stated ingredient other than water : Ingredient contains a carbon atom double bonded to oxygen, e.g., carboxylic acid, etc. : Nitrogen compound contains a nitrogen atom bonded to three carbon atoms and wherein none of the carbon atoms are double-bonded to oxygen)
Patent 5686502: Water blown, hydrophilic, open cell polyurethane foams, method of making such foams and articles made therefrom
(SYNTHETIC RESINS OR NATURAL RUBBERS -- PART OF THE CLASS 520 SERIES : : CELLULAR PRODUCTS OR PROCESSES OF PREPARING A CELLULAR PRODUCT, E.G., FOAMS, PORES, CHANNELS, ETC. : Cellular product derived from a -N=C=X containing reactant wherein X is a chalcogen atom : With -XH reactant wherein X is a chalcogen atom : -XH reactant contains a C-X-C group : With non -C=X containing reactant)
Patent 5686503: Method of generating a reactive species and applications therefor
(SYNTHETIC RESINS OR NATURAL RUBBERS -- PART OF THE CLASS 520 SERIES : : COMPOSITIONS TO BE POLYMERIZED BY WAVE ENERGY WHEREIN SAID COMPOSITION CONTAINS A RATE-AFFECTING MATERIAL; OR COMPOSITIONS TO BE MODIFIED BY WAVE ENERGY WHEREIN SAID COMPOSITION CONTAINS A RATE-AFFECTING MATERIAL; OR PROCESSES OF PREPARING OR TREATING A SOLID POLYMER UTILIZING WAVE ENERGY : Compositions to be polymerized or modified by wave energy wherein said composition contains at least one specified rate-affecting material; or processes of preparing or treating a solid polymer utilizing wave energy in the presence of at least one specified rate-affecting material; e.g., nitrogen containing photosensitizer, oxygen containing photoinitiator, etc. wave energy in order to prepare a cellular product : Specified rate-affecting material contains a ketone group -c-(CO)n-c-, the (CO)n not being part of a ring : Containing two or more ketone groups : Specified rate-affecting material contains only carbon, hydrogen, or halogen and at least one atom of carbon is bonded to hydrogen or a halogen atom)
Patent 5686504: Pigmented, UV-cured, acrylic-based, pressure sensitive adhesives, and method for making same
(SYNTHETIC RESINS OR NATURAL RUBBERS -- PART OF THE CLASS 520 SERIES : : COMPOSITIONS TO BE POLYMERIZED BY WAVE ENERGY WHEREIN SAID COMPOSITION CONTAINS A RATE-AFFECTING MATERIAL; OR COMPOSITIONS TO BE MODIFIED BY WAVE ENERGY WHEREIN SAID COMPOSITION CONTAINS A RATE-AFFECTING MATERIAL; OR PROCESSES OF PREPARING OR TREATING A SOLID POLYMER UTILIZING WAVE ENERGY : Compositions to be polymerized or modified by wave energy wherein said composition contains at least one specified rate-affecting material; or processes of preparing or treating a solid polymer utilizing wave energy in the presence of at least one specified rate-affecting material; e.g., nitrogen containing photosensitizer, oxygen containing photoinitiator, etc. wave energy in order to prepare a cellular product : Specified rate-affecting material contains a ketone group -c-(CO)n-c-, the (CO)n not being part of a ring : At least two aryl groups connected directly to same carbonyl carbon, e.g., benzophenone, etc. : Containing C-CO-CHOH-CHOR wherein R is organic)
Patent 5686505: Process and apparatus for surface treatment of unvulcanized rubber sheet
(SYNTHETIC RESINS OR NATURAL RUBBERS -- PART OF THE CLASS 520 SERIES : : COMPOSITIONS TO BE POLYMERIZED BY WAVE ENERGY WHEREIN SAID COMPOSITION CONTAINS A RATE-AFFECTING MATERIAL; OR COMPOSITIONS TO BE MODIFIED BY WAVE ENERGY WHEREIN SAID COMPOSITION CONTAINS A RATE-AFFECTING MATERIAL; OR PROCESSES OF PREPARING OR TREATING A SOLID POLYMER UTILIZING WAVE ENERGY : Processes of treating a solid polymer derived from ethylenic monomers only; or compositions therefore : Solid polymer derived from monomer containing only carbon and hydrogen : Halogen is fluorine)
|